Bronte Capital Management Pty Ltd. Has $39,000 Stock Position in Corteva, Inc. $CTVA

Posted by Teresa Graham on Feb 5th, 2026

Bronte Capital Management Pty Ltd. trimmed its stake in Corteva, Inc. (NYSE:CTVA – Free Report) by 11.9% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 571,018 shares of the company’s stock after selling 76,802 shares during the period. Corteva comprises approximately 0.0% of Bronte Capital Management Pty Ltd.’s investment portfolio, making the stock its 24th biggest position. Bronte Capital Management Pty Ltd. owned approximately 0.08% of Corteva worth $39,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. Gladwyn Financial Advisors Inc. bought a new position in shares of Corteva during the 2nd quarter worth approximately $25,000. Total Investment Management Inc. acquired a new position in Corteva during the second quarter worth $27,000. Activest Wealth Management raised its holdings in shares of Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after acquiring an additional 200 shares during the last quarter. Curat Global LLC raised its stake in shares of Corteva by 93.7% in the second quarter. Curat Global LLC now owns 370 shares of the company’s stock worth $28,000 after purchasing an additional 179 shares during the last quarter. Finally, True Wealth Design LLC lifted its holdings in shares of Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after purchasing an additional 264 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Trading Up 0.1%

Shares of Corteva stock opened at $75.08 on Thursday. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $77.41. The company has a 50 day simple moving average of $68.60 and a two-hundred day simple moving average of $68.40. The firm has a market cap of $50.73 billion, a PE ratio of 47.52, a PEG ratio of 1.91 and a beta of 0.75. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.58 and a quick ratio of 1.07.

Corteva (NYSE:CTVA – Get Free Report) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting the consensus estimate of $0.22. The firm had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. Corteva had a return on equity of 8.97% and a net margin of 6.29%.The company’s revenue was down 1.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be issued a $0.18 dividend. The ex-dividend date is Monday, March 2nd. This represents a $0.72 annualized dividend and a dividend yield of 1.0%. Corteva’s dividend payout ratio (DPR) is currently 30.77%.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a report on Thursday, January 22nd. Deutsche Bank Aktiengesellschaft cut their price objective on Corteva from $90.00 to $85.00 and set a “buy” rating on the stock in a research report on Thursday, November 6th. Weiss Ratings restated a “hold (c-)” rating on shares of Corteva in a research report on Monday, December 29th. Wells Fargo & Company reduced their price objective on Corteva from $80.00 to $77.00 and set an “overweight” rating for the company in a report on Tuesday, November 11th. Finally, Mizuho upped their price target on shares of Corteva from $78.00 to $80.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $79.58.

View Our Latest Stock Analysis on Corteva

More Corteva News

Here are the key news stories impacting Corteva this week:

Positive Sentiment: Management raised FY‑2026 EPS guidance to $3.45–$3.70, above the Street — a clear sign of confidence in profitable growth, margin expansion and controllable drivers. Strong 2H and Full Year 2025 Results (PR Newswire)
Positive Sentiment: Company emphasized strong second half and full‑year 2025 performance, record free cash flow and operational discipline (product mix, cost saves, working‑capital efficiency) that support shareholder returns and reinvestment. Q4 Earnings Call Highlights (Yahoo Finance)
Neutral Sentiment: Q4 EPS was roughly in line with consensus ($0.22 reported; some outlets note a slight beat vs. estimates), which de‑risks near‑term earnings surprises but does not offset revenue weakness. CTVA Surpasses Q4 Earnings Estimates (Zacks)
Negative Sentiment: Q4 revenue missed expectations ($3.91B vs. ~$4.23B est.) — management cites seasonal timing shifts and weaker crop‑protection and seed demand as drivers, prompting downward pressure on the stock in after‑hours trading. Corteva misses quarterly sales estimates (MSN)
Negative Sentiment: Market commentary highlights that the revenue shortfall was partly timing‑related but still widened losses on certain lines and sparked a near‑term selloff (reports of ~3% after‑hours decline). Monitor if demand softness persists into planting seasons. Corteva shares fall as seasonal timing shifts drive Q4 revenue miss (Investing.com) Corteva falls after-hours as Q4 revenue misses (Seeking Alpha)

About Corteva

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.